Subendocardial enhancement in gadolinium-diethylene-triamine- pentaacetic acid-enhanced magnetic resonance imaging in aortic stenosis

American Journal of Cardiology

Volumn 83, Issue 10, 1999, Pages 1443-1446

  Ochiai, Koichi ^a   Ishibashi, Yutaka ^a   Shimada, Toshio ^a   Murakami, Yo ^a   Inoue, Shin Ichi ^a   Sano, Kazuya ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; AORTA VALVE STENOSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENDOCARDIUM; FEMALE; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE INJURY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESSURE GRADIENT; PRIORITY JOURNAL;

ADULT; AGED; AORTIC VALVE STENOSIS; CONTRAST MEDIA; EVALUATION STUDIES; FEMALE; GADOLINIUM DTPA; HEMODYNAMIC PROCESSES; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 0033562687     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00122-8     Document Type: Article

References (24)

1. Matheijssen N.A., de Roos A., van der Wall E.E., Doornbos J., van Dijkman P.R., Bruschke A.V., van Voorthuisen A.E. Acute myocardial infarction comparison of T2-weighted and T1-weighted gadolinium-DTPA enhanced MR imaging . Magn Reson Med. 17:1989;460-469.
2. van der Wall E.E., van Dijkman P.R., de Roos A., Doornbos J., van der Laarse A., Manger Cats V., van Voorthuisen A.E., Matheijssen N.A., Bruschke A.V. Diagnostic significance of gadolinium-DTPA (diethylentriamine penta-acetic acid) enhanced magnetic resonance imaging in thrombolytic treatment for acute myocardial infarction its potential in assessing reperfusion . Br Heart J. 63:1990;12-17.
3. Yokota C., Nonogi H., Miyazaki S., Goto Y., Maeno M., Daikoku S., Itoh A., Haze K., Yamada N. Gadolinium-enhanced magnetic resonance imaging in acute myocardial infarction. Am J Cardiol. 75:1995;577-581.
4. Matsuoka H., Hamada M., Honda T., Kawakami H., Okayama H., Abe M., Shigematsu Y., Sumimoto T., Hiwada K. Precise assessment of myocardial damage associated with secondary cardiomyopathies by use of Gd-DTPA-enhanced magnetic resonance imaging. Angiology. 44:1993;945-950.
5. Friedrich M.G., Strohm O., Schulz-Menger J., Marciniak H., Luft F.C., Dietz R. Contrast-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation. 97:1998;1802-1809.
6. Whynne J., Green L.H., Mann T., Levin D., Grossman W. Estimation of left ventricular volume in man from biplane cineangiograms filmed in oblique projections. Am J Cardiol. 41:1978;726-732.
7. Coolins H.W., Kronenberg M.W., Byrd B.F. III. Reproducibility of left ventricular mass measurements by two-dimensional and M-mode echocardiography. J Am Coll Cardiol. 14:1989;672-676.
8. Conway M.A., Allis J., Ouwerkerk R., Niioka T., Rajagopalan B., Radda G. Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by P-31 magnetic resonance spectroscopy. Lancet. 338:1991;937-976.
9. Neubauer S., Horn M., Pabst T., Harre K., Stromer H., Bertsch G., Sandstede J., Ertl G., Hahn D., Kochsiek K. Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy. J Investig Med. 45:1997;453-462.
10. Sarda L., Faraggi M., Brochet E., Vissuzaine C., Delahaye N., Le Guludec D. Acute diffuse myocyte necrosis evidenced with 111 In-antimyosin antibody scintigraphy in a patient with aortic stenosis. J Nucl Cardiol. 4:1997;426-427.
11. Silver M.A., Pick R., Brilla C.G., Jalil J.E., Janicki J.S., Weber K.T. Reactive and reparative fibrillar collagen remodeling in the hypertrophied rat left ventricle two experimental models of myocardial fibrosis . Cardiovasc Res. 24:1990;741-747.
12. Laine G.A., Allen S.J. Left ventricular myocardial edema. Lymph flow, interstitial fibrosis, and cardiac function. Circ Res. 68:1991;1713-1721.
13. Doering C.W., Jalil J.E., Janicki J.S., Pick R., Aghili S., Abrahams C., Weber K.T. Collagen network remodeling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res. 22:1988;686-695.
14. Ishihara K., Zile M.R., Nagatsu M., Nakano K., Tomita M., Kanazawa S., Clamp L., DeFreyte G., Carabello B.A. Coronary blood flow after the regression of pressure-overload left ventricular hypertrophy. Circ Res. 71:1992;1472-1481.
15. Camici P.G., Cecchi F., Gistri R., Montereggi A., Salvadori P.A., Dolara A., L'Abbate A. Dipyridamole-induced subendocardial underperfusion in hypertrophic cardiomyopathy assessed by positron-emission tomography. Coron Artery Dis. 2:1991;837-841.
16. Gistri R., Cecchi F., Choudhury L., Montereggi A., Sorace O., Salvadori P.A., Camici P.G. Effect of verapamil on absolute myocardial blood flow in hypertrophic cardiomyopathy. Am J Cardiol. 74:1994;363-368.
17. Choudhury L., Rosen S.D., Patel D., Nihoyannopoulos P., Camici P.G. Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography. Eur Heart J. 18:1997;108-116.
18. Hittinger L., Shannon R.P., Bishop S.P., Gelpi R.J., Vatner S.F. Subendomyocardial exhaustion of blood flow reserve and increased fibrosis in conscious dogs with heart failure. Circ Res. 65:1989;971-980.
19. Hutchins G.M., Kuhajda F.P., Moore G.W. Myocardial injury in patients with aortic stenosis. Am J Cardiovasc Pathol. 1:1987;31-37.
20. Jantunen E., Haline M.O., Romppanen T., Kosma V.M., Collan Y. Morphometric study of human myocardium in acquired valvular diseases. Ann Med. 21:1989;435-440.
21. Tsukihashi H., Ishibashi Y., Shimada T., Hatano J., Tanabe K., Ooyake N., Morioka S., Moriyama K. Changes in gadolinium-DTPA enhanced magnetic resonance signal intensity ratio in hypertrophic cardiomyopathy. J Cardiol. 24:1994;185-191.
22. Inoue S, Murakami Y, Ochiai K, Kitamura J, Ishibashi Y, Kawamitsu H, Sugimura K, Shimada T. The Contributory Role of Interstitial Water in Gd-DTPA-enhanced MRI in Myocardial Infarction. J Magon Reson Imaging 1999; in press.
23. Aso H., Takeda K., Ito T., Shiraishi T., Matsumura K., Nakagawa T. Assessment of myocardial fibrosis in cardiomyopathic hamsters with gadolinium-DTPA enhanced magnetic resonance imaging. Invest Radiol. 33:1998;22-32.
24. Kim R.J., Chen E.L., Lima J.A., Judd R.M. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation. 94:1996;3318-3326.